Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The Horizon Results Platform organises a number of webinars for start-ups and SMEs:
We also would like to point out that more interesting sessions can be found on the Horizon Results Platform TV, a learning tool with the objective to support and inspire participants in research and innovation programmes.
2024-11-26
|
19 hours ago |
Female entrepreneurs in EU start-ups on the up but still low |
2024-11-05
|
3 weeks ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
2024-10-28
|
4 weeks ago |
New European Research Area Communication adopted by the European Commission |
2024-10-23
|
1 month ago |
Future of the European Programme for Research and Innovation - state of play of posit... |
2024-10-21
|
1 month ago |
Temporary suspension of the EIC Accelerator short proposals submissions |
2024-10-15
|
1 month ago |
Annual report on implementation of the EU budget for the financial year 2023 by Eur... |
2024-10-07
|
1 month ago |
NCP Flanders Job Vacancy: administrative support |
2024-09-23
|
2 months ago |
Number of submitted proposals EIC-transition-open |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Deployment: Best use of technologies
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.